Global Monoclonal Mouse Antibody Market Size, Status and Forecast 2020-2026

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
For antibody discovery, mice are one of the most important sources. They produce similar antibody isotypes with human, including IgA, IgD, IgE, IgG and IgM. Compared with the subclasses of human antibody isotypes, mice contain only one IgA class and the IgG subclasses are known as IgG1, IgG2a, IgG2b and IgG3. In addition, laboratory mice can induce a good immune response to a great range of antigens, even those highly homological human proteins. Moreover, some treatments that unacceptable for humans can also be aboveboard applied for mice with results which are analogous to that from humans. Therefore, the development of mouse monoclonal antibodies is a common choice for a variety of therapeutics and pathology researches. Up to now, the rapid development of therapeutic antibody in the pharmaceutical industry has enabled the mice to play an important role in both monoclonal antibodies discovery and the pre-clinical assessment.
Market Analysis and Insights: Global Monoclonal Mouse Antibody Market
In 2019, the global Monoclonal Mouse Antibody market size was US$ 8180.6 million and it is expected to reach US$ 11870 million by the end of 2026, with a CAGR of 5.4% during 2021-2026.
Global Monoclonal Mouse Antibody Scope and Market Size
Monoclonal Mouse Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Mouse Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Monoclonal Mouse Antibody market is segmented into IgM, IgG, IgA, Other, etc.
Segment by Application, the Monoclonal Mouse Antibody market is segmented into Therapeutic, Research, Diagnostic, etc.
Regional and Country-level Analysis
The Monoclonal Mouse Antibody market is analysed and market size information is provided by regions (countries).
The key regions covered in the Monoclonal Mouse Antibody market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Monoclonal Mouse Antibody Market Share Analysis
Monoclonal Mouse Antibody market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Monoclonal Mouse Antibody business, the date to enter into the Monoclonal Mouse Antibody market, Monoclonal Mouse Antibody product introduction, recent developments, etc.
The major vendors include Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics, etc.

This report focuses on the global Monoclonal Mouse Antibody status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Monoclonal Mouse Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Market segment by Type, the product can be split into

IgM
IgG
IgA
Other

Market segment by Application, split into

Therapeutic
Research
Diagnostic

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Monoclonal Mouse Antibody status, future forecast, growth opportunity, key market and key players.
To present the Monoclonal Mouse Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Monoclonal Mouse Antibody are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions